Llwytho...
Ticagrelor-Induced Prolongation of the QTc Interval
BACKGROUND: Ticagrelor has been accepted as a class I antiplatelet agent in patients undergoing percutaneous coronary angioplasty (PTCA). There have been cases reported on ticagrelor being associated with various cardiac conduction defects. But there is no evidence of QTc prolongation associated wit...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Case Rep Cardiol |
|---|---|
| Prif Awduron: | , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Hindawi
2019
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6881594/ https://ncbi.nlm.nih.gov/pubmed/31827937 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/5984847 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|